Success Stories

ValueDo supported a Country Head at a top 20 pharma’s EU affiliate with the redesign of the organization’s commercial operating model, go-to-market approach and their internal organization design.

We helped transform from brand-centric to customer-centric operating model, and improved the customer engagement framework, organizational design, ways-of-working and accountability for both HQ and field-facing roles.

ValueDo supported the Global Head of biosimilars and his team at a top 20 global pharma organization to first set up the this new business segment – biosimilars, and then assisted the team over 4 years with multiple initiatives: business strategy, 2 US brand launches, CEO-led growth initiative, launch excellence across US, Canada, EU and international markets, and other operational exercises.

ValueDo supported the Head of US Oncology Diagnostics at a top 5 US pharmaceutical organization to design and implement a clear field operations strategy to improve the value of Oncology diagnostic liaisons for ‘patient identification’, and to maximize the overall value of the Diagnostics function to Oncology organization.

ValueDo supported the VP of Global Biologics organization at top 10 pharma to conceptualize, plan, and execute business cases for the franchise. We analyzed market drivers to discover unmet needs, market size, access, and penetration rates and conducted an in-depth competitor analysis. Utilizing the company’s skills and unique qualifications, we crafted strategies to identify new opportunities with brands and investments.

ValueDo supported a top 5 US pharma Neurosciences franchise with end-to-end launch planning and management support for one of their key brand launches.

The engagement started with a launch diagnostic, progressed to brand insight and strategy refinement, and was followed by co-creation and implementation against an 18-month cross-functional launch and operational planning.

This was accomplished by a cadence of long-range planning sessions, workshops, deep-dives, 1-1s and launch tracking with US-Global and cross-functional teams.

Pivotal was day 0 execution on milestones, communications and asset deliveries across all functions.

Post-launch operational planning support was provided to maintain launch momentum. Seen as a successful launch by the management, we also assisted with a launch excellence exercise with other regions.

ValueDo supported Respiratory Market Development organization at a top 5 US pharma to streamline their patient engagement approach across the entire franchise.

Different teams within the therapy area used to reach out to patients through multiple campaigns, initiatives and assets. This led to fragmented patient engagement. ValueDo supported this transformation via a 3 phase initiative – discovery, design of a minimal viable product (MVP), and implementation.

ValueDo supported franchise heads and their marketing leaders to scale and implement a global omnichannel medical and marketing methodology for 3 of their biologics brands across 15+ countries and all business regions. This included omnichannel subject-matter expertise, agile coaching, lean program and change management support, and implementation of a robust omnichannel methodology.

ValueDo supported a marketing leader at top 10 pharma to conceptualize, design, and implement an alternate healthcare provider engagement model to generate new patient starts for a complex IV product. We aligned with key marketing, ops-support, and sales stakeholders to align branding and messaging, provided additional brand awareness to company offices, and provided onboarding and training for the selected telemarketing partner.